Related references
Note: Only part of the references are listed.Drug Repurposing: Promises of Edaravone Target Drug in Traumatic Brain Injury
Zaynab Shakkour et al.
CURRENT MEDICINAL CHEMISTRY (2021)
Selective nanoparticle-mediated targeting of renal tubular Toll-like receptor 9 attenuates ischemic acute kidney injury.
Sang Jun Han et al.
KIDNEY INTERNATIONAL (2020)
Renal proximal tubular NEMO plays a critical role in ischemic acute kidney injury
Sang Jun Han et al.
JCI INSIGHT (2020)
Regulated necrosis and failed repair in cisplatin-induced chronic kidney disease
Sarah Landau et al.
KIDNEY INTERNATIONAL (2019)
Edaravone-caffeine combination for the effective management of rotenone induced Parkinson's disease in rats: An evidence based affirmative from a comparative analysis of behavior and biomarker expression
Maria Bandookwala et al.
NEUROSCIENCE LETTERS (2019)
Potential use of edaravone to reduce specific side effects of chemo-, radio- and immuno-therapy of cancers
Christian Bailly
INTERNATIONAL IMMUNOPHARMACOLOGY (2019)
Semi-quantitative Determination of Protein Expression Using Immunohistochemistry Staining and Analysis: An Integrated Protocol
Alexandra R. Crowe et al.
BIO-PROTOCOL (2019)
Selective Nanoparticle Targeting of the Renal Tubules
Ryan M. Williams et al.
HYPERTENSION (2018)
Tumor targeting via EPR: Strategies to enhance patient responses
Susanne K. Golombek et al.
ADVANCED DRUG DELIVERY REVIEWS (2018)
DNA origami nanostructures can exhibit preferential renal uptake and alleviate acute kidney injury
Dawei Jiang et al.
NATURE BIOMEDICAL ENGINEERING (2018)
RIPK3 promotes sepsis-induced acute kidney injury via mitochondrial dysfunction
Angara Sureshbabu et al.
JCI INSIGHT (2018)
The impact of cumulative dose of cisplatin on outcome of patients with head and neck squamous cell carcinoma
A. Al-Mamgani et al.
EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY (2017)
Antioxidant Drug Approved for ALS
Rebecca Voelker
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
The Economic Consequences of Acute Kidney Injury
Samuel A. Silver et al.
NEPHRON (2017)
Edaravone Prevents Retinal Degeneration in Adult Mice Following Optic Nerve Injury
Goichi Akiyama et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2017)
Role of Pharmacogenomics in Kidney Disease and Injury
Linda Awdishu et al.
ADVANCES IN CHRONIC KIDNEY DISEASE (2016)
Immune Monitoring of Trans-endothelial Transport by Kidney-Resident Macrophages
Efstathios G. Stamatiades et al.
CELL (2016)
Long-Term Renal Outcomes after Cisplatin Treatment
Sheron Latcha et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2016)
Nanomedicines for kidney diseases
Ryan M. Williams et al.
KIDNEY INTERNATIONAL (2016)
Targeted fibrillar nanocarbon RNAi treatment of acute kidney injury
Simone Alidori et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Targeting nitrative stress for attenuating cisplatin-induced downregulation of cochlear LIM domain only 4 and ototoxicity
Samson Jamesdaniel et al.
REDOX BIOLOGY (2016)
Sirtuin 3-dependent mitochondrial dynamic improvements protect against acute kidney injury
Marina Morigi et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Mesoscale Nanoparticles Selectively Target the Renal Proximal Tubule Epithelium
Ryan M. Williams et al.
NANO LETTERS (2015)
EPR or no EPR? The billion-dollar question
Andrew Z. Wang
Science Translational Medicine (2015)
Cisplatin-induced apoptosis in auditory, renal, and neuronal cells is associated with nitration and downregulation of LMO4
R. Rathinam et al.
CELL DEATH DISCOVERY (2015)
Cancer nanotechnology: The impact of passive and active targeting in the era of modern cancer biology
Nicolas Bertrand et al.
ADVANCED DRUG DELIVERY REVIEWS (2014)
The link between acute kidney injury and chronic kidney disease
Linda Y. Belayev et al.
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2014)
Tubular p53 Regulates Multiple Genes to Mediate AKI
Dongshan Zhang et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2014)
Protective Effect of Metalloporphyrins against Cisplatin-Induced Kidney Injury in Mice
Hao Pan et al.
PLOS ONE (2014)
Pathophysiology of Cisplatin-Induced Acute Kidney Injury
Abdullah Ozkok et al.
BIOMED RESEARCH INTERNATIONAL (2014)
Nitrotyrosine Level Was Associated with Mortality in Patients with Acute Kidney Injury
Jing Qian et al.
PLOS ONE (2013)
Enabling Innovative Translational Research in Acute Kidney Injury
Abolfazl Zarjou et al.
CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2012)
Schisandrin B, attenuates cisplatin-induced oxidative stress, genotoxicity and neurotoxicity through modulating NF-κB pathway in mice
Vijayasree V. Giridharan et al.
FREE RADICAL RESEARCH (2012)
In vivo regulation of the heme oxygenase-1 gene in humanized transgenic mice
Junghyun Kim et al.
KIDNEY INTERNATIONAL (2012)
Fiji: an open-source platform for biological-image analysis
Johannes Schindelin et al.
NATURE METHODS (2012)
Investigating mechanisms of chronic kidney disease in mouse models
Allison A. Eddy et al.
PEDIATRIC NEPHROLOGY (2012)
Toxicities of Targeted Therapy and Their Management in Kidney Cancer
Giuseppe Di Lorenzo et al.
EUROPEAN UROLOGY (2011)
Apoptosis and acute kidney injury
Andrea Havasi et al.
KIDNEY INTERNATIONAL (2011)
A critical assessment of edaravone acute ischemic stroke efficacy trials: is edaravone an effective neuroprotective therapy?
Paul A. Lapchak
EXPERT OPINION ON PHARMACOTHERAPY (2010)
Everolimus in Patients with Autosomal Dominant Polycystic Kidney Disease
Gerd Walz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Long-term outcomes of acute kidney injury
Ryan Goldberg et al.
ADVANCES IN CHRONIC KIDNEY DISEASE (2008)
Epidemiology of acute kidney injury: How big is the problem?
Eric A. J. Hoste et al.
CRITICAL CARE MEDICINE (2008)
Potent free radical scavenger, edaravone, suppresses oxidative stress-induced endothelial damage and early atherosclerosis
Hang Xi et al.
ATHEROSCLEROSIS (2007)
Pharmacologic treatment of acute kidney injury: why drugs haven't worked and what is on the horizon
Sang Kyung Jo et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
Phenotypic heterogeneity of the endothelium II. Representative vascular beds
William C. Aird
CIRCULATION RESEARCH (2007)
Formulation of functionalized PLGA-PEG nanoparticles for in vivo targeted drug delivery
Jianjun Cheng et al.
BIOMATERIALS (2007)
Investigation of the therapeutic effects of edaravone, a free radical scavenger, on amyotrophic lateral sclerosis (Phase II study)
Hiide Yoshino et al.
AMYOTROPHIC LATERAL SCLEROSIS (2006)
Incidence and mortality of acute renal failure in Medicare beneficiaries, 1992 to 2001
Jay L. Xue et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
Edaravone reduces early accumulation of oxidative products and sequential inflammatory responses after transient focal ischemia in mice brain
N Zhang et al.
STROKE (2005)
Differential gender differences in ischemic and nephrotoxic acute renal failure
QQ Wei et al.
AMERICAN JOURNAL OF NEPHROLOGY (2005)
Edaravone inhibits acute renal injury and cyst formation in cisplatin-treated rat kidney
T Iguchi et al.
FREE RADICAL RESEARCH (2004)
Plasma and urinary free 3-nitrotyrosine following cardiac angiography procedures with non-ionic radiocontrast media
E Fiaccadori et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2004)
Differential gene expression following early renal ischemia/reperfusion
S Supavekin et al.
KIDNEY INTERNATIONAL (2003)
Effect of a novel free radical scavenger, edaravone (MCI-186), on acute brain infarction - Randomized, placebo-controlled, double-blind study at multicenters
E Otomo et al.
CEREBROVASCULAR DISEASES (2003)
Sexual dimorphism in renal ischemia-reperfusion injury in rats:: Possible role of endothelin
V Müller et al.
KIDNEY INTERNATIONAL (2002)
Increased nitrotyrosine staining in kidneys from patients with diabetic nephropathy
RC Thuraisingham et al.
KIDNEY INTERNATIONAL (2000)
Share Paper
